GlassScriptPhysician profile
Marcia A Dover
NPI 1356452312
$4,969.13
in general payments reported to CMS, 2019-2025
20 companies · $1,456 in 2025
The $1,456 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $145 · 2020: $34.03 · 2021: $91.69 · 2022: $375 · 2023: $2,032 · 2024: $834 · 2025: $1,456.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,345 · Consulting Fee: $1,900 · Education: $78.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,344.52 |
| Consulting Fee | $1,900.00 |
| Education | $78.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Argenx US, INC. | $2,021.84 | 2023-2025 | Vyvgart |
| Abbvie INC. | $672.69 | 2021-2025 | |
| Pfizer INC. | $496.17 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $344.57 | 2024-2025 | |
| Amneal Pharmaceuticals LLC | $285.26 | 2023-2025 | Crexont, Rytary, Ongentys 50mg Capsules 30 |
| Lilly USA, LLC | $264.55 | 2023-2025 | Kisunla, Amyvid |
| Abbott Laboratories | $195.85 | 2022-2024 | Infinity |
| Sunovion Pharmaceuticals INC. | $168.81 | 2019-2020 | |
| Sk Life Science, INC. | $117.26 | 2023-2025 | |
| Teva Pharmaceuticals USA, INC. | $113.93 | 2023-2025 | Austedo Xr |
| Lundbeck LLC | $60.45 | 2024-2025 | Vyepti |
| Mdd US Operations, LLC | $51.73 | 2024-2025 | Apokyn |
| Celgene Corporation | $33.65 | 2025 | Zeposia |
| Emd Serono, INC. | $29.52 | 2022-2023 | Mavenclad |
| Biogen, INC. | $28.77 | 2019-2025 | Leqembi |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ge Healthcare | $24.08 | 2025 | |
| Ucb, INC. | $17.36 | 2021 | |
| Alexion Pharmaceuticals, INC. | $15.10 | 2024 | Ultomiris |
| Livanova USA, INC. | $14.64 | 2023 | Vns Therapy Sentiva Model 1000 Generator |
| Amgen INC. | $12.90 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marcia Dover listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.